SCHEMBL6409758

SCHEMBL6409758

Fc1ccc(CSc2nnc(-c3cccs3)[nH]2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.56
RAB9A P51151 9/20 0.56
NPC1 O15118 7/20 0.56
HPGD P15428 3/20 0.55
NPSR1 Q6W5P4 2/20 0.55
TSHR P16473 1/20 0.55
MAPK1 P28482 1/20 0.55
PTGS2 P35354 1/20 0.47
LMNA P02545 2/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 6/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 4/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RXFP1 Q9HBX9 2/20 0.43
ABL1 P00519 1/20 0.42
RET P07949 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6403770 0.86 SMN1; SMN2 (0.44) SMN1; SMN2RAB9ANPC1HPGDNPSR1
SCHEMBL6404560 0.83 HPGD (0.51) SMN1; SMN2RAB9ANPC1HPGDNPSR1
SCHEMBL6406549 0.79 MAPT (0.51) SMN1; SMN2RAB9ANPC1HPGDNPSR1
SCHEMBL6429452 0.76 CTSB (0.47) HPGDNPSR1HTTMAPTKDM4E
SCHEMBL6404584 0.76 RAB9A (0.48) SMN1; SMN2RAB9ANPC1HPGDTSHR
SCHEMBL6403484 0.75 ADORA3 (0.41) SMN1; SMN2RAB9ANPC1HPGDMAPK1
SCHEMBL6410721 0.74 BCAT1 (0.40) SMN1; SMN2RAB9ANPC1HPGDNPSR1
SCHEMBL6406156 0.73 GRK6 (0.59) SMN1; SMN2RAB9ANPC1HPGDNPSR1
SCHEMBL6405499 0.73 ALDH1A1 (0.46) SMN1; SMN2RAB9ANPC1HPGDNPSR1
SCHEMBL16171148 0.72 MEN1 (0.54) SMN1; SMN2RAB9ANPC1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT SMN1; SMN2 4793/4885RAB9A 4278/4885NPC1 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.